Form 4: Raymond James Director Esty Acquires 1,303 DRSUs
Insider Transaction Report
Raymond James Financial Director Benjamin Esty acquired 1,303 Deferred Restricted Stock Units as part of his compensation for board service.
Summary
- Benjamin Esty, a Director at Raymond James Financial Inc (RJF), acquired 1,303 Deferred Restricted Stock Units (DRSUs).
- The transaction occurred on February 19, 2026, and the DRSUs were granted at a price of $0.0000.
- Following this acquisition, Mr. Esty beneficially owns 31,794 securities, which include these DRSUs.
- The DRSUs are part of his compensation for service on the registrant's Board of Directors.
- Upon vesting, the DRSUs convert to common stock on a one-to-one basis and include accrued cash in lieu of dividends.
- Vesting will occur at the date of the next annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following the grant.
- Settlement of the DRSUs is deferred until Mr. Esty terminates his service on the Board of Directors, based on an irrevocable election.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It's a routine compensation grant that aligns director interests with shareholders, which is generally a positive for corporate governance, but it does not indicate any new operational or financial performance.
Positives
- The grant of Deferred Restricted Stock Units aligns the director's interests with those of shareholders, as the value of his compensation is tied to the company's stock performance.
- Equity compensation for non-executive directors is a common practice that promotes long-term commitment and strategic oversight.
Risks
- The value of the Deferred Restricted Stock Units is subject to the future market price fluctuations of Raymond James Financial Inc's common stock.
- The deferral of settlement until termination of board service means the director's compensation is locked in for an extended period, subject to market volatility.
Future Outlook
The Deferred Restricted Stock Units are expected to vest at the next annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following the grant. Settlement of these units will be deferred until the director terminates his service on the Board of Directors.
Industry Context
StockSavvy.ai notes that the grant of Deferred Restricted Stock Units to a non-executive director is a standard practice within the financial services industry. This form of equity compensation is widely used to align the interests of board members with those of long-term shareholders, encouraging prudent governance and strategic decisions that enhance shareholder value. This particular transaction is consistent with typical compensation structures for directors at publicly traded financial institutions.
Comparison to Industry Standards
- The use of Deferred Restricted Stock Units (DRSUs) as part of non-executive director compensation is a common practice across the financial services sector, similar to structures seen at peers like Morgan Stanley or Charles Schwab.
- Granting equity at a $0.0000 price is standard for compensation awards, reflecting that these are not purchased but earned for service.
- The vesting schedule tied to the annual shareholders meeting and the deferral of settlement until board termination are typical mechanisms designed to retain directors and ensure long-term alignment with company performance, comparable to practices at other large financial firms.
Related Party Transactions
- The grant of Deferred Restricted Stock Units to Director Benjamin Esty constitutes a related party transaction, as it involves compensation from the company to a member of its Board of Directors. This is a standard and disclosed form of compensation.
Stakeholder Impact
- Shareholders: The grant of equity compensation to a director aligns their financial interests with those of shareholders, potentially encouraging decisions that enhance long-term shareholder value.
- Employees: No direct impact on general employees is indicated by this specific filing.
Next Steps
- The DRSUs will vest at the next annual shareholders meeting following the grant date, or by March 15 of the calendar year following grant, whichever is earlier.
- The settlement of the DRSUs will occur upon Benjamin Esty's termination of service on the Board of Directors.
Key Dates
| Date | Description |
|---|---|
| 02/19/2026 | Date of transaction: Acquisition of 1,303 Deferred Restricted Stock Units (DRSUs) by Director Benjamin Esty. |
| 02/23/2026 | Date the Form 4 was signed by Jonathan J. Doyle as Attorney-in-Fact for Benjamin C. Esty. |
| March 15 of the calendar year following grant (latest) | Latest possible vesting date for the DRSUs, which will occur at the next annual shareholders meeting following the grant date. |
| Upon termination of Board service | Settlement date for the DRSUs, deferred following vesting due to an irrevocable election by the reporting person. |
Recommendation
holdThis Form 4 filing reports a routine insider transaction involving director compensation through an equity grant. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction is expected and aligns director interests, but does not materially alter the investment thesis for Raymond James Financial Inc.
Keywords
Raymond James Financial, RJF, Benjamin Esty, Director Compensation, Deferred Restricted Stock Units, DRSUs, Insider Transaction, Equity Grant, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.